ACAD Company Profile and Key Details

Q: Who are the executives of ACAD?

Dr. Srdjan R. Stankovic M.D., M.S.P.H.PresMr. Austin D. KimExecutive Vice President, Gen. Counsel & Sec.Mr. James K. KiharaVice President, Chief Accounting Officer & Corporation ControllerMr. Bob MischlerSenior Vice President of Strategy & Technology OperationsMr. Mark C. JohnsonVice President of Investor RelationsMs. Julie FisherSenior Vice President of Marketing & Commercial StrategyMr. Mark C. SchneyerExecutive Vice President & Chief Financial OfficerDr. Mary Ellen TurnerSenior Vice President of Pharmacovigilance & Corporation Safety OfficerMr. Rob AcklesSenior Vice President & Chief People OfficerMs. Holly ValdiviezSenior Vice President & Head of SalesMs. Ponni Subbiah M.D., M.P.H.SVice President, Global Head of Medical Affairs & Chief Medical OfficerMr. Brendan P. TeehanExecutive Vice President, Chief Operating Officer & Head of CommercialMr. Stephen R. Davis J.D.Pres, Chief Executive Officer & Director

NASDAQ : ACAD

ACADIA Pharmaceuticals

$22.58

0.42+1.90%

At Close 4:00 PM

62.35

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

ACADIA Pharmaceuticals Inc. (ACAD) stock surged +1.90%, trading at $22.58 on NASDAQ, up from the previous close of $22.16. The stock opened at $21.94, fluctuating between $21.51 and $22.62 in the recent session.

Stock Snapshot

22.16

Prev. Close

3.85B

Market Cap

21.51

Day Low

9.82

P/E Ratio

2.3

EPS (TTM)

-0.14

Cash Flow per Share

21.94

Open

170.49M

Number of Shares

22.62

Day High

99.21%

Free Float in %

2.62

Book Value

1.39M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 09, 2026	21.94	22.62	21.51	22.58	1.71M
Mar 06, 2026	22.04	22.31	21.63	22.16	1.32M
Mar 03, 2026	22.34	22.96	22.28	22.50	1.95M
Mar 02, 2026	24.21	24.34	22.73	22.81	2.99M
Feb 27, 2026	24.34	25.36	24.21	24.56	1.77M
Feb 26, 2026	23.64	25.04	22.46	24.64	3.95M
Feb 25, 2026	24.64	25.10	24.30	24.97	1.8M
Feb 24, 2026	25.04	25.19	24.49	24.59	1.47M
Feb 23, 2026	24.78	24.97	23.99	24.73	2.9M
Feb 20, 2026	24.01	24.22	23.58	23.99	2.24M
Feb 19, 2026	23.04	24.56	22.88	24.33	1.9M
Feb 18, 2026	22.80	23.27	22.59	23.20	1.06M
Feb 17, 2026	21.94	23.06	21.90	22.95	1.81M
Feb 13, 2026	21.89	22.19	21.79	22.03	885.07K
Feb 12, 2026	22.46	22.58	21.51	21.61	1.23M
Feb 11, 2026	22.89	22.92	22.15	22.47	977.46K
Feb 10, 2026	23.14	23.26	22.66	22.70	1.11M
Feb 09, 2026	23.38	23.54	23.02	23.22	1.53M
Feb 06, 2026	24.04	24.04	23.37	23.56	2.36M
Feb 05, 2026	24.50	24.67	23.37	23.46	1.18M

Contact Details

San Diego, CA 92130

United States

https://www.acadia-pharm.com 858 558 2871

About Company

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Stock Peers

REGN

21.74+2.86%

Regeneron Pharmaceuticals, Inc.$781.60 ARGX

22.6+3.15%

argenx SE$740.40 UTHR

51.01+10.67%

United Therapeutics Corporation$529.17 VRTX

4.18+0.92%

Vertex Pharmaceuticals Incorporated$460.87 MDGL

0.37+0.09%

Madrigal Pharmaceuticals, Inc.$433.20 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

2.93+0.91%

Alnylam Pharmaceuticals, Inc.$323.59 PRAX

-1.7-0.55%

Praxis Precision Medicines, Inc.$309.01 KRYS

4.96+1.96%

Krystal Biotech, Inc.$258.65 ASND

-0.73-0.30%

Ascendis Pharma A/S$239.92

Frequently Asked Questions

What is the current ACADIA Pharmaceuticals Inc. (ACAD) stock price?

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock price is $22.58 in the last trading session. During the trading session, ACAD stock reached the peak price of $22.62 while $21.51 was the lowest point it dropped to. The percentage change in ACAD stock occurred in the recent session was 1.9% while the dollar amount for the price change in ACAD stock was $0.42.

ACAD's industry and sector of operation?

The NASDAQ listed ACAD is part of Biotechnology industry that operates in the broader Healthcare sector. ACADIA Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ACAD?

Dr. Srdjan R. Stankovic M.D., M.S.P.H.
Pres
Mr. Austin D. Kim
Executive Vice President, Gen. Counsel & Sec.
Mr. James K. Kihara
Vice President, Chief Accounting Officer & Corporation Controller
Mr. Bob Mischler
Senior Vice President of Strategy & Technology Operations
Mr. Mark C. Johnson
Vice President of Investor Relations
Ms. Julie Fisher
Senior Vice President of Marketing & Commercial Strategy
Mr. Mark C. Schneyer
Executive Vice President & Chief Financial Officer
Dr. Mary Ellen Turner
Senior Vice President of Pharmacovigilance & Corporation Safety Officer
Mr. Rob Ackles
Senior Vice President & Chief People Officer
Ms. Holly Valdiviez
Senior Vice President & Head of Sales
Ms. Ponni Subbiah M.D., M.P.H.
SVice President, Global Head of Medical Affairs & Chief Medical Officer
Mr. Brendan P. Teehan
Executive Vice President, Chief Operating Officer & Head of Commercial
Mr. Stephen R. Davis J.D.
Pres, Chief Executive Officer & Director

How ACAD did perform over past 52-week?

ACAD's closing price is 68.51% higher than its 52-week low of $13.40 where as its distance from 52-week high of $28.35 is -20.35%.

How many employees does ACAD have?

Number of ACAD employees currently stands at 653.

Link for ACAD official website?

Official Website of ACAD is: https://www.acadia-pharm.com

How do I contact ACAD?

ACAD could be contacted at phone 858 558 2871 and can also be accessed through its website. ACAD operates from 12830 El Camino Real, San Diego, CA 92130, United States.

How many shares of ACAD are traded daily?

ACAD stock volume for the day was 1.39M shares. The average number of ACAD shares traded daily for last 3 months was 1.5M.

What is the market cap of ACAD currently?

The market value of ACAD currently stands at $3.85B with its latest stock price at $22.58 and 170.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	653
Beta	0.81
Sales or Revenue	$726.44M
5Y Sales Change%	1.508%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	653
Beta	0.81
Sales or Revenue	$726.44M
5Y Sales Change%	1.508%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ACAD Company Profile and Key Details

ACADIA Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Earnings & Analyst Outlook

Valuation Metrics

Key Takeaways

Price Forecast & Outlook